Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Maxlinear Inc
F:JMX
Maxlinear Inc
F:JMX
Price:
58.34
EUR
-2.41%
Market Closed
Market Cap:
€4.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Maxlinear Inc
F:JMX
|
US |
|
C
|
Chugai Pharmaceutical Co Ltd
DUS:CUP
|
JP |
|
W
|
Wesizwe Platinum Ltd
JSE:WEZ
|
ZA |
Wall St Price Targets
JMX Price Forecast
Based on 13 analysts
Based on 13 analysts
-65% Downside
from
€58.34
today
Maxlinear Inc (JMX)’s 12-month stock price forecast through October 2027 has a consensus target of €20.27, implying 65% downside. The forecast is based on price targets from 13 Wall Street analysts.
JMX Analyst Rating
No ratings yet
No ratings yet
Maxlinear Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is JMX's stock price target?
Price Target
20.27
EUR
20.27
EUR
According to Wall Street analysts, the average 1-year price target for JMX is 20.27 EUR with a low forecast of 15.65 EUR and a high forecast of 26.08 EUR.
What is the Revenue forecast for Maxlinear Inc?
Projected CAGR
36%
36%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 36%.
What is the Gross Profit forecast for Maxlinear Inc?
Projected CAGR
39%
39%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 39%.